FDA Approves First AI-Powered Radiation Exposure Reduction Solution
|
By MedImaging International staff writers Posted on 16 Apr 2019 |
|
Image: The FDA has cleared FluoroShield, the first AI-powered radiation exposure reduction solution (Photo courtesy of Omega Medical Imaging).
An artificial intelligence (AI) powered region of interest (ROI) radiation exposure reduction solution for interventional X-ray imaging has received clearance from the US FDA. The solution named FluoroShield has been developed by Omega Medical Imaging (Sanford, FL, USA) in conjunction with its technology partner IKOMED Technologies (Vancouver, BC Canada). Omega Medical Imaging designs, manufactures, delivers, and supports Interventional X-Ray Imaging devices for hospitals and healthcare facilities around the globe. IKOMED Technologies is a medical device company developing novel medical solutions based on proprietary technology.
FluoroShield is available only on Omega Medical Imaging’s Flat Panel detector CS-series product lines. It combines the power of AI, an ultra-fast collimator and the world’s most advanced image processing to deliver a ROI solution that has shown to reduce radiation exposure up to ~84%, seamlessly helping interventional clinicians to reach their ALARA goals. According to the company, the FluoroShield system utilizes AI to minimize X-ray dose to patients and staff, and uses TruBlock technology to completely block radiation. It delivers maximum radiation reduction, while optimizing workflow and achieves NextLevel image quality.
“FluoroShield is a critical piece of our innovation pipeline of solutions aimed at helping our partners deliver the best in patient outcomes and efficiencies,” said Brian Fleming, President of Omega Medical Imaging.
Related Links:
Omega Medical Imaging
IKOMED Technologies
 Guided Devices.jpg)
FluoroShield is available only on Omega Medical Imaging’s Flat Panel detector CS-series product lines. It combines the power of AI, an ultra-fast collimator and the world’s most advanced image processing to deliver a ROI solution that has shown to reduce radiation exposure up to ~84%, seamlessly helping interventional clinicians to reach their ALARA goals. According to the company, the FluoroShield system utilizes AI to minimize X-ray dose to patients and staff, and uses TruBlock technology to completely block radiation. It delivers maximum radiation reduction, while optimizing workflow and achieves NextLevel image quality.
“FluoroShield is a critical piece of our innovation pipeline of solutions aimed at helping our partners deliver the best in patient outcomes and efficiencies,” said Brian Fleming, President of Omega Medical Imaging.
Related Links:
Omega Medical Imaging
IKOMED Technologies
X-Ray Illuminator
X-Ray Viewbox Illuminators
Multi-Use Ultrasound Table
Clinton
Biopsy Software
Affirm® Contrast
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Latest Industry News News
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Channels
Radiography
view channel
AI Helps Radiologists Spot More Lesions in Mammograms
Breast cancer is a critical health issue, and accurate detection through mammography is essential for effective treatment. However, interpreting mammograms can be challenging for radiologists, particularly... Read more
AI Detects Fatty Liver Disease from Chest X-Rays
Fatty liver disease, which results from excess fat accumulation in the liver, is believed to impact approximately one in four individuals globally. If not addressed in time, it can progress to severe conditions... Read more
MRI
view channel
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read more
New MRI Technique Reveals Hidden Heart Issues
Traditional exercise stress tests conducted within an MRI machine require patients to lie flat, a position that artificially improves heart function by increasing stroke volume due to gravity-driven blood... Read more
Ultrasound
view channel
Pain-Free Breast Imaging System Performs One Minute Cancer Scan
Breast cancer is one of the leading causes of death for women worldwide, and early detection is key to improving outcomes. Traditional methods like mammograms and ultrasound have their limitations, particularly... Read more
Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery
Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more
Nuclear Medicine
view channel
Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more
New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
Prostate cancer is the second leading cause of cancer-related death among men in the United States. However, the majority of older men diagnosed with prostate cancer have slow-growing, low-risk forms of... Read more
General/Advanced Imaging
view channel
CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
As colorectal cancer remains the second leading cause of cancer-related deaths worldwide, early detection through screening is vital to reduce advanced-stage treatments and associated costs.... Read more
First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
Currently, patients with conditions such as heart failure, pneumonia, or respiratory distress often require multiple imaging procedures that are intermittent, disruptive, and involve high levels of radiation.... Read more
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
